Altered natural killer cell subset homeostasis and defective chemotactic responses in paroxysmal nocturnal hemoglobinuria

Blood

Volumn 122, Issue 11, 2013, Pages 1887-1890

  El Sherbiny, Yasser M ^a,b   Kelly, Richard J ^a   Hill, Anita ^a   Doody, Gina M ^a   Hillmen, Peter ^a   Cook, Graham P ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CD160 ANTIGEN; CD48 ANTIGEN; CD56 ANTIGEN; CD59 ANTIGEN; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; GLYCOSYLPHOSPHATIDYLINOSITOL; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; LYMPHOCYTE ANTIGEN; PIGA PROTEIN; PROTEIN; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG; CXCL12 PROTEIN, HUMAN; CXCR4 PROTEIN, HUMAN;

ARTICLE; BLOOD; CELL DIFFERENTIATION; CELL HOMING; CELL MIGRATION; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; GENE MUTATION; HOMEOSTASIS; HUMAN; HUMAN CELL; LIPID RAFT; MEMBRANE MICRODOMAIN; NATURAL KILLER CELL; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; PROTEIN CONFORMATION; CELL CULTURE; CELL LINE; CELL MOTION; DRUG EFFECT; FLOW CYTOMETRY; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; PATHOLOGY;

ANTIGENS, CD56; CELL LINE; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CXCL12; CHEMOTAXIS; FLOW CYTOMETRY; GPI-LINKED PROTEINS; HEMOGLOBINURIA, PAROXYSMAL; HOMEOSTASIS; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; RECEPTORS, CXCR4;

EID: 84887349396     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-06-507574     Document Type: Article

References (25)

1. Paulick MG, Bertozzi CR. The glycosylphosphatidylinositol anchor: a complex membrane-anchoring structure for proteins. Biochemistry. 2008;47(27):6991-7000.
2. Brodsky RA. How I treat paroxysmal nocturnal hemoglobinuria. Blood. 2009;113(26):6522-6527.
3. Pu JJ, Brodsky RA. Paroxysmal nocturnal hemoglobinuria from bench to bedside. Clin Transl Sci. 2011;4(3):219-224.
4. Caligiuri MA. Human natural killer cells. Blood. 2008;112(3):461-469.
5. bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood. 2003;101(8):3052-3057.
6. Ferlazzo G, Thomas D, Lin SL, et al. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol. 2004;172(3):1455-1462.
7. Brodsky RA, Mukhina GL, Li S, Nelson KL, Chiurazzi PL, Buckley JT, Borowitz MJ. Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin. Am J Clin Pathol. 2000;114(3):459-466.
8. Richards SJ, Norfolk DR, Swirsky DM, Hillmen P. Lymphocyte subset analysis and glycosylphosphatidylinositol phenotype in patients with paroxysmal nocturnal hemoglobinuria. Blood. 1998;92(5):1799-1806.
9. dim cells: role of contact with peripheral fibroblasts. J Immunol. 2007;179(1):89-94.
10. Huntington ND, Legrand N, Alves NL, et al. IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J Exp Med. 2009;206(1):25-34.
11. dim human NK-cell subsets. Blood. 2010;115(2):274-281.
12. bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation. J Immunol. 2004;173(10):6418-6426.
13. Villanueva J, Lee S, Giannini EH, Graham TB, Passo MH, Filipovich A, Grom AA. Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther. 2005;7(1):R30-R37.
14. + NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol. 2001; 166(11):6477-6482.
15. Berahovich RD, Lai NL, Wei Z, Lanier LL, Schall TJ. Evidence for NK cell subsets based on chemokine receptor expression. J Immunol. 2006; 177(11):7833-7840.
16. Nguyen DH, Taub D. CXCR4 function requires membrane cholesterol: implications for HIV infection. J Immunol. 2002;168(8):4121-4126.
17. Wysoczynski M, Reca R, Ratajczak J, et al. Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient. Blood. 2005;105(1):40-48.
18. Szpurka H, Schade AE, Jankowska AM, Maciejewski JP. Altered lipid raft composition and defective cell death signal transduction in glycosylphosphatidylinositol anchor-deficient PIG-A mutant cells. Br J Haematol. 2008;142(3): 413-422.
19. Alfinito F, Ruggiero G, Sica M, et al. Eculizumab treatment modifies the immune profile of PNH patients. Immunobiology. 2012;217(7):698-703.
20. Bennett LD, Fox JM, Signoret N. Mechanisms regulating chemokine receptor activity. Immunology. 2011;134(3):246-256.
21. Xia Z, Liu Q, Berger CT, et al. A 17q12 allele is associated with altered NK cell subsets and function. J Immunol. 2012;188(7):3315-3322.
22. Dingli D, Luzzatto L, Pacheco JM. Neutral evolution in paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci USA. 2008; 105(47):18496-18500.
23. Ratajczak J, Kucia M, Mierzejewska K, et al. A novel view of paroxysmal nocturnal hemoglobinuria pathogenesis: more motile PNH hematopoietic stem/progenitor cells displace normal HSPCs from their niches in bone marrow due to defective adhesion, enhanced migration and mobilization in response to erythrocyte-released sphingosine-1 phosphate gradient. Leukemia. 2012;26(7):1722-1725.
24. Funaro A, Ortolan E, Ferranti B, Gargiulo L, Notaro R, Luzzatto L, Malavasi F. CD157 is an important mediator of neutrophil adhesion and migration. Blood. 2004;104(13):4269-4278.
25. Takedachi M, Qu D, Ebisuno Y, et al. CD73-generated adenosine restricts lymphocyte migration into draining lymph nodes. J Immunol. 2008;180(9):6288-6296.